A Review of Approaches for Predicting Drug–Drug Interactions Based on Machine Learning
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Drug–drug interactions play a vital role in drug research. However, they may also cause adverse reactions in patients, with serious consequences. Manual detection of drug–drug interactions is time-consuming and expensive, so it is urgent to use computer methods to solve the problem. There are two ways for computers to identify drug interactions: one is to identify known drug interactions, and the other is to predict unknown drug interactions. In this paper, we review the research progress of machine learning in predicting unknown drug interactions. Among these methods, the literature-based method is special because it combines the extraction method of DDI and the prediction method of DDI. We first introduce the common databases, then briefly describe each method, and summarize the advantages and disadvantages of some prediction models. Finally, we discuss the challenges and prospects of machine learning methods in predicting drug interactions. This review aims to provide useful guidance for interested researchers to further promote bioinformatics algorithms to predict DDI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Comprehensive Survey on Graph Neural Networks
Wu, Z., Pan, S., Chen, F., Long, G., Zhang, C., & Yu, P. S. (2021) · IEEE Transactions on Neural Networks and Learning Systems · doi:10.1109/tnnls.2020.2978386 · Cited by 11,000 · cited 4×
“Lable propagation, recursive least squares (RSL), traversal of graph and other methods are also used for link prediction Graph embedding Decagon Wu et al., 2020, Feng et al. (2020), Ma et al. (2018”
BackgroundMethodInfluentialKEGG: new perspectives on genomes, pathways, diseases and drugs
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y., & Morishima, K. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1092 · Cited by 8,865
Incidence of Adverse Drug Reactions in Hospitalized Patients: A Meta-analysis of Prospective Studies
Lazarou, J., Pomeranz, B. H., & Corey, P. N. (1998) · JAMA · doi:10.1001/jama.279.15.1200 · Cited by 4,807
PubChem 2019 update: improved access to chemical data
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1033 · Cited by 3,249
KEGG for representation and analysis of molecular networks involving diseases and drugs
Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp896 · Cited by 2,322 · cited 1×
“Moreover, extracting DDI from unstructured text data does not provide an early warning or identify unknown DDI, while machine learning can effectively predict it in advance (Kanehisa et al., 2010; Chen et al., 2019; Song et al., 2021).”
BackgroundModeling polypharmacy side effects with graph convolutional networks
Zitnik, M., Agrawal, M., & Leskovec, J. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty294 · Cited by 1,501
The SIDER database of drugs and side effects
Kuhn, M., Letunic, I., Jensen, L. J., & Bork, P. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1075 · Cited by 1,451
Data-driven prediction of drug effects and interactions
Tatonetti, N. P., Ye, P. P., Daneshjou, R., & Altman, R. B. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003377 · Cited by 936
Hohl, C. M., Dankoff, J., Colacone, A., & Afilalo, M. (2001) · Annals of Emergency Medicine · doi:10.1067/mem.2001.119456 · Cited by 477
Metalearning: A survey of trends and technologies
Lemke, C., Budka, M., & Gabrys, B. (2015) · Artificial Intelligence Review · doi:10.1007/s10462-013-9406-y · Cited by 365 · cited 1×
“Deepika and Geetha (2018) predicted DDI through positive-unlabeled (PU) learning (Elkan and Keith, 2008) and meta-learning (Lemke et al., 2015), and proposed a learning framework for semi-supervised classifiers based on SVM.”
BackgroundTarget identification among known drugs by deep learning from heterogeneous networks
Zeng, X., Zhu, S., Lu, W., Liu, Z., Huang, J., Zhou, Y., Fang, J., Huang, Y., Guo, H., Li, L., et al. (2020) · Chemical Science · doi:10.1039/c9sc04336e · Cited by 357
A review of network-based approaches to drug repositioning
Lotfi Shahreza, M., Ghadiri, N., Mousavi, S. R., Varshosaz, J., & Green, J. R. (2018) · Briefings in Bioinformatics · doi:10.1093/bib/bbx017 · Cited by 330
Drug Similarity Integration Through Attentive Multi-view Graph Auto-Encoders
Ma, T., Xiao, C., Zhou, J., & Wang, F. (2018) · Proceedings of the Twenty-Seventh International Joint Conference on Artificial Intelligence · doi:10.24963/ijcai.2018/483 · Cited by 220
Tatonetti, N. P., Fernald, G. H., & Altman, R. B. (2012) · Journal of the American Medical Informatics Association · doi:10.1136/amiajnl-2011-000214 · Cited by 203 · cited 1×
“The most commonly used databases are: DrugBank (Knox et al., 2010), SIDER (Kuhn et al., 2016), TWOSIDES (Tatonetti et al., 2012a), Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa et al., 2017).”
MethodSu, R., Wu, H., Xu, B., Liu, X., & Wei, L. (2019) · IEEE/ACM Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2018.2858756 · Cited by 134 · cited 1×
“With regard to drug similarity, interactions between new drugs are predicted through the fusion of similar characteristics of multiple drugs (Su et al., 2019a; Zeng et al., 2019; Zeng et al., 2020a; Fu et al., 2020; Mo et al., 2020; Zhuang et al., 2020; Shaker et al., 2021).”
Background
Cited by
Revolutionizing healthcare: the role of artificial intelligence in clinical practice
Alowais, S. A., Alghamdi, S. S., Alsuhebany, N., Alqahtani, T., Alshaya, A. I., Almohareb, S. N., Aldairem, A., Alrashed, M., Bin Saleh, K., Badreldin, H. A., et al. (2023) · BMC Medical Education · doi:10.1186/s12909-023-04698-z · Cited by 3,146
“This can help to reduce the risk of adverse drug reactions, and cost and improve patient outcomes [59].”
BackgroundBenefits, Limits, and Risks of GPT-4 as an AI Chatbot for Medicine
Lee, P., Bubeck, S., & Petro, J. (2023) · New England Journal of Medicine · doi:10.1056/nejmsr2214184 · Cited by 1,738
Artificial intelligence in the field of pharmacy practice: A literature review
Chalasani, S. H., Syed, J., Ramesh, M., Patil, V., & Pramod Kumar, T. M. (2023) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2023.100346 · Cited by 162
“42,43 Pre-dicting DDI necessitates the use of multiple drug characteristics and known DDI.”
BackgroundPolypharmacy and precision medicine
Fujita, K., Masnoon, N., Mach, J., O’Donnell, L. K., & Hilmer, S. N. (2023) · Cambridge Prisms: Precision Medicine · doi:10.1017/pcm.2023.10 · Cited by 27
Attention-based approach to predict drug–target interactions across seven target superfamilies
Schulman, A., Rousu, J., Aittokallio, T., & Tanoli, Z. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btae496 · Cited by 25
Metadata
- Authors
- Han, K., Cao, P., Wang, Y., Xie, F., Ma, J., Yu, M., Wang, J., Xu, Y., Zhang, Y., & Wan, J.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2022-01-28
- Volume
- 12
- Pages
- 814858-814858
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W4210567899
- Cited by
- 173
- References
- 15
- FWCI
- 17.99
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.